Helena Cirule

1.2k total citations
34 papers, 907 citations indexed

About

Helena Cirule is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Helena Cirule has authored 34 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Biochemistry, 18 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Helena Cirule's work include Metabolism and Genetic Disorders (19 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Diet and metabolism studies (7 papers). Helena Cirule is often cited by papers focused on Metabolism and Genetic Disorders (19 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Diet and metabolism studies (7 papers). Helena Cirule collaborates with scholars based in Latvia, Sweden and Russia. Helena Cirule's co-authors include Maija Dambrova, Edgars Liepinsh, Janis Kuka, Marina Makrecka‐Kuka, Reinis Vilšķe̅rsts, Solveiga Grı̄nberga, Ivars Kalvinsh, Osvalds Pugovičs, Elīna Makarova and Baiba Švalbe and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Helena Cirule

34 papers receiving 886 citations

Peers

Helena Cirule

PHYSI

CCM

PFM

Reinis Vilšķe̅rsts Latvia

Min Ho South Korea

Jeanette Schultz Johansen Norway

Gökhan Sadı Türkiye

Pankaj K. Bagul India

I. Grattagliano Italy

Kapil Suchal India

Guei‐Jane Wang Taiwan

Adrian Sturza Romania

Abdalla M. El‐Mowafy Egypt

Reinis Vilšķe̅rsts Latvia

Helena Cirule

740 ×1.6

373 ×1.4

PHYSI

318 ×1.4

154 ×1.4

CCM

109 ×1.1

PFM

Citations per year, relative to Helena Cirule Helena Cirule (= 1×) peers Reinis Vilšķe̅rsts

Countries citing papers authored by Helena Cirule

Since Specialization

Citations

This map shows the geographic impact of Helena Cirule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Cirule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Cirule more than expected).

Fields of papers citing papers by Helena Cirule

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Cirule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Cirule. The network helps show where Helena Cirule may publish in the future.

Co-authorship network of co-authors of Helena Cirule

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Cirule. A scholar is included among the top collaborators of Helena Cirule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Cirule. Helena Cirule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grı̄nberga, Solveiga, et al.. (2024). Innovative Approach to Enhance Bioavailability of Birch Bark Extracts: Novel Method of Oleogel Development Contrasted with Other Dispersed Systems. Plants. 13(1). 145–145. 1 indexed citations

Liepinsh, Edgars, Liga Zvejniece, Edijs Vavers, et al.. (2024). Hydroxymethylglutaryl‐CoA reductase activity is essential for mitochondrial β‐oxidation of fatty acids to prevent lethal accumulation of long‐chain acylcarnitines in the mouse liver. British Journal of Pharmacology. 181(16). 2750–2773. 6 indexed citations

Vilšķe̅rsts, Reinis, Kārlis Vilks, Helena Cirule, et al.. (2021). Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19. International Journal of Molecular Sciences. 23(1). 45–45. 10 indexed citations

Kuka, Janis, Marina Makrecka‐Kuka, Kārlis Vilks, et al.. (2021). Inhibition of Fatty Acid Metabolism Increases EPA and DHA Levels and Protects against Myocardial Ischaemia‐Reperfusion Injury in Zucker Rats. Oxidative Medicine and Cellular Longevity. 2021(1). 7493190–7493190. 5 indexed citations

Vilšķe̅rsts, Reinis, et al.. (2021). Microbiota-Derived Metabolite Trimethylamine N-Oxide Protects Mitochondrial Energy Metabolism and Cardiac Functionality in a Rat Model of Right Ventricle Heart Failure. Frontiers in Cell and Developmental Biology. 8. 622741–622741. 31 indexed citations

Makrecka‐Kuka, Marina, Kārlis Vilks, Helena Cirule, et al.. (2020). Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism in a Mouse Model of Diet-Induced Lipid Overload. Cardiovascular Drugs and Therapy. 34(6). 791–797. 25 indexed citations

Latkovskis, Gustavs, Elīna Makarova, Dace Hartmane, et al.. (2018). Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine‐N‐oxide. British Journal of Clinical Pharmacology. 84(11). 2634–2644. 13 indexed citations

Vilšķe̅rsts, Reinis, Janis Kuka, Edgars Liepinsh, et al.. (2015). Methyl-γ-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis. Vascular Pharmacology. 72. 101–107. 14 indexed citations

Makrecka‐Kuka, Marina, Janis Kuka, Kristine Volska, et al.. (2014). Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria. Molecular and Cellular Biochemistry. 395(1-2). 1–10. 47 indexed citations

10.

Kuka, Janis, Edgars Liepinsh, Marina Makrecka‐Kuka, et al.. (2014). Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. Life Sciences. 117(2). 84–92. 75 indexed citations

11.

Liepinsh, Edgars, Marina Makrecka‐Kuka, Janis Kuka, et al.. (2014). Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size. Pharmacological Research. 85. 33–38. 16 indexed citations

12.

Liepinsh, Edgars, Marina Makrecka‐Kuka, Janis Kuka, et al.. (2013). The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism. 63(1). 127–136. 56 indexed citations

13.

Liepinsh, Edgars, Elina Skapare, Janis Kuka, et al.. (2013). Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(6). 541–550. 43 indexed citations

14.

Liepinsh, Edgars, Elina Skapare, Baiba Švalbe, et al.. (2011). Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. European Journal of Pharmacology. 658(2-3). 277–283. 27 indexed citations

15.

Liepinsh, Edgars, Reinis Vilšķe̅rsts, Liga Zvejniece, et al.. (2009). Protective effects of mildronate in an experimental model of type 2 diabetes in Goto‐Kakizaki rats. British Journal of Pharmacology. 157(8). 1549–1556. 57 indexed citations

16.

Liepinsh, Edgars, Janis Kuka, Baiba Švalbe, et al.. (2009). Effects of Long‐Term Mildronate Treatment on Cardiac and Liver Functions in Rats. Basic & Clinical Pharmacology & Toxicology. 105(6). 387–394. 27 indexed citations

17.

Liepinsh, Edgars, Reinis Vilšķe̅rsts, Elina Skapare, et al.. (2008). Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart. Life Sciences. 83(17-18). 613–619. 57 indexed citations

18.

Dambrova, Maija, Helena Cirule, Baiba Švalbe, et al.. (2008). Effect of inhibiting carnitine biosynthesis on male rat sexual performance. Physiology & Behavior. 95(3). 341–347. 24 indexed citations

19.

Dambrova, Maija, Helena Cirule, Claes Post, et al.. (2002). The novel guanidine ME10092 protects the heart during ischemia–reperfusion. European Journal of Pharmacology. 445(1-2). 105–113. 5 indexed citations

20.

Dambrova, Maija, et al.. (1999). Cardioprotective effects of N‐hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats. British Journal of Pharmacology. 128(5). 1089–1097. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact